Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 2
2007 1
2008 3
2009 3
2010 1
2011 2
2012 2
2013 1
2014 1
2016 2
2017 2
2018 2
2019 4
2020 1
2021 3
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
The immunology of renal cell carcinoma.
Díaz-Montero CM, Rini BI, Finke JH. Díaz-Montero CM, et al. Nat Rev Nephrol. 2020 Dec;16(12):721-735. doi: 10.1038/s41581-020-0316-3. Epub 2020 Jul 30. Nat Rev Nephrol. 2020. PMID: 32733094 Review.
Immunobiology of Melanoma.
Phoon YP, Tannenbaum C, Diaz-Montero CM. Phoon YP, et al. Among authors: diaz montero cm. Clin Plast Surg. 2021 Oct;48(4):561-576. doi: 10.1016/j.cps.2021.06.005. Epub 2021 Aug 6. Clin Plast Surg. 2021. PMID: 34503717 Review.
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression.
Pavicic PG Jr, Rayman PA, Swaidani S, Rupani A, Makarov V, Tannenbaum CS, Edwards RP, Vlad AM, Diaz-Montero CM, Mahdi H. Pavicic PG Jr, et al. Among authors: diaz montero cm. Oncoimmunology. 2023 Apr 10;12(1):2198185. doi: 10.1080/2162402X.2023.2198185. eCollection 2023. Oncoimmunology. 2023. PMID: 37066116 Free PMC article.
Increased Incidence of Venous Thromboembolism with Cancer Immunotherapy.
Roopkumar J, Swaidani S, Kim AS, Thapa B, Gervaso L, Hobbs BP, Wei W, Alban TJ, Funchain P, Kundu S, Sangwan N, Rayman P, Pavicic PG Jr, Diaz-Montero CM, Barnard J, McCrae KR, Khorana AA. Roopkumar J, et al. Among authors: diaz montero cm. Med. 2021 Apr 9;2(4):423-434. doi: 10.1016/j.medj.2021.02.002. Epub 2021 Mar 12. Med. 2021. PMID: 34036293 Free PMC article.
Tumor-derived exosomes induce CD8+ T cell suppressors.
Maybruck BT, Pfannenstiel LW, Diaz-Montero M, Gastman BR. Maybruck BT, et al. Among authors: diaz montero m. J Immunother Cancer. 2017 Aug 15;5(1):65. doi: 10.1186/s40425-017-0269-7. J Immunother Cancer. 2017. PMID: 28806909 Free PMC article.
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.
Wilkerson AD, Parthasarathy PB, Stabellini N, Mitchell C, Pavicic PG Jr, Fu P, Rupani A, Husic H, Rayman PA, Swaidani S, Abraham J, Budd GT, Moore H, Al-Hilli Z, Ko JS, Baar J, Chan TA, Alban T, Diaz-Montero CM, Montero AJ. Wilkerson AD, et al. Among authors: diaz montero cm. Clin Cancer Res. 2024 Jan 5;30(1):82-93. doi: 10.1158/1078-0432.CCR-23-1349. Clin Cancer Res. 2024. PMID: 37882661 Free PMC article. Clinical Trial.
A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.
Li C, Phoon YP, Karlinsey K, Tian YF, Thapaliya S, Thongkum A, Qu L, Matz AJ, Cameron M, Cameron C, Menoret A, Funchain P, Song JM, Diaz-Montero CM, Tamilselvan B, Golden JB, Cartwright M, Rodriguez A, Bonin C, Vella A, Zhou B, Gastman BR. Li C, et al. Among authors: diaz montero cm. J Exp Med. 2022 Jan 3;219(1):e20202084. doi: 10.1084/jem.20202084. Epub 2021 Nov 22. J Exp Med. 2022. PMID: 34807232 Free PMC article.
32 results